John P. Sharp - Aug 3, 2021 Form 4/A - Amendment Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Role
Chief Financial Officer
Signature
/s/ John P. Sharp
Stock symbol
PHASQ
Transactions as of
Aug 3, 2021
Transactions value $
$12,600
Form type
4/A - Amendment
Date filed
9/3/2021, 04:41 PM
Date Of Original Report
Aug 4, 2021
Previous filing
May 24, 2021
Next filing
Nov 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Options Exercise $12.6K +7.5K +17.55% $1.68* 50.2K Aug 3, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHASQ Employee Stock Option (right to buy) Options Exercise $0 -7.5K -7.1% $0.00 98.1K Aug 3, 2021 Common Stock 7.5K $1.68 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amended to correct the transaction code for common stock acquired through stock options exercised in a transaction on August 3, 2021.
F2 Amended to add a transaction for the exercise of stock options on August 3, 2021.
F3 All shares underlying this option have vested.